BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38710519)

  • 1. [Research progress on ferroptosis in tumor immunity].
    Ji J; Liu S; Liao X; Wang D; Zhu H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Apr; 40(4):362-366. PubMed ID: 38710519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of ferroptosis in cancer: a matter of context?
    Catanzaro E; Demuynck R; Naessens F; Galluzzi L; Krysko DV
    Trends Cancer; 2024 May; 10(5):407-416. PubMed ID: 38368244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
    Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine in cancer immunology and immunotherapy. Current status and new perspectives.
    Sarasola MP; Táquez Delgado MA; Nicoud MB; Medina VA
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00778. PubMed ID: 34609067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages.
    Sun C; Zhan J; Li Y; Zhou C; Huang S; Zhu X; Huang K
    J Cell Mol Med; 2024 Apr; 28(8):e18348. PubMed ID: 38652105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Interactions of Autophagy with the Immune System and Cancer.
    Jin Y; Hong Y; Park CY; Hong Y
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic regulation of ferroptosis in the tumor microenvironment.
    Mbah NE; Lyssiotis CA
    J Biol Chem; 2022 Mar; 298(3):101617. PubMed ID: 35065965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
    Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
    Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis is an effective strategy for cancer therapy.
    Khan A; Huo Y; Guo Y; Shi J; Hou Y
    Med Oncol; 2024 Apr; 41(5):124. PubMed ID: 38652406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis of immune cells in the tumor microenvironment.
    Kim R; Taylor D; Vonderheide RH; Gabrilovich DI
    Trends Pharmacol Sci; 2023 Aug; 44(8):542-552. PubMed ID: 37380530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment.
    Zhu W; Liu X; Yang L; He Q; Huang D; Tan X
    Eur J Pharmacol; 2023 Dec; 961():176124. PubMed ID: 37925133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
    Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity.
    Shi L; Liu Y; Li M; Luo Z
    FEBS J; 2022 Jul; 289(13):3655-3665. PubMed ID: 34042258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis in antitumor therapy: Unraveling regulatory mechanisms and immunogenic potential.
    Zhang T; Zeng X; Zeng E; Wang H
    Int Immunopharmacol; 2024 Jun; 134():112203. PubMed ID: 38705030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells.
    Liang W; Ferrara N
    Front Immunol; 2020; 11():626812. PubMed ID: 33679721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
    Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
    J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic ferroptosis and where to find it?
    Demuynck R; Efimova I; Naessens F; Krysko DV
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
    Xu Z; Chen X; Song L; Yuan F; Yan Y
    Front Immunol; 2022; 13():834595. PubMed ID: 35281049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
    Zhou Q; Meng Y; Li D; Yao L; Le J; Liu Y; Sun Y; Zeng F; Chen X; Deng G
    Signal Transduct Target Ther; 2024 Mar; 9(1):55. PubMed ID: 38453898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity.
    Xu C; Sun S; Johnson T; Qi R; Zhang S; Zhang J; Yang K
    Cell Rep; 2021 Jun; 35(11):109235. PubMed ID: 34133924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.